Your browser doesn't support javascript.
loading
The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study.
Benjamin, David J; Chen, Shuai; Eldredge, Joanna B; Schokrpur, Shiruyeh; Li, Debory; Quan, Zhikuan; Chan, Jason W; Cummings, Amy L; Daly, Megan E; Goldman, Jonathan W; Gubens, Matthew A; Harris, Jeremy P; Onaitis, Mark W; Zhu, Viola W; Patel, Sandip P; Kelly, Karen.
Affiliation
  • Benjamin DJ; Divsion of Hematology/Oncology, Department of Medicine, University of California Irvine, Irvine, California.
  • Chen S; Present Address: 1 Hoag Drive, Building 51, Newport Beach, California.
  • Eldredge JB; Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis, California.
  • Schokrpur S; Division of Hematology and Oncology, Department of Medicine, University of California Davis School of Medicine, Sacramento, California.
  • Li D; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla, California.
  • Quan Z; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Chan JW; Division of Biostatistics, Department of Public Health Sciences, University of California Davis, Davis, California.
  • Cummings AL; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California.
  • Daly ME; Division of Hematology Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Goldman JW; Department of Radiation Oncology, University of California Davis School of Medicine, Sacramento, California.
  • Gubens MA; Division of Hematology Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Harris JP; Division of Hematology Oncology, Department of Medicine, University of California San Francisco, San Francisco, California.
  • Onaitis MW; Department of Radiation Oncology, University of California Irvine, Irvine, California.
  • Zhu VW; Division of Hematology-Oncology, Department of Medicine, University of California, San Diego School of Medicine, La Jolla, California.
  • Patel SP; Division of Cardiothoracic Surgery, Department of Surgery, University of California, San Diego, La Jolla, California.
  • Kelly K; Divsion of Hematology/Oncology, Department of Medicine, University of California Irvine, Irvine, California.
JTO Clin Res Rep ; 3(12): 100427, 2022 Dec.
Article in En | MEDLINE | ID: mdl-36426286
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: JTO Clin Res Rep Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: JTO Clin Res Rep Year: 2022 Type: Article